Restructuring and Related Impairments (Tables)

12 Months Ended

Dec. 31, 2025

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve by Type of Cost

The Company’s restructuring and impairment expenses are comprised of the following (in millions):

	Fiscal Year Ended December 31, 2025
	Cost of revenue		Selling, general  and administrative		Total
Severance and employee costs	$	0.3	$	0.9	$	1.2
	Fiscal Year Ended December 31, 2024
	Cost of revenue		Selling, general  and administrative		Total
Severance and employee costs	$	0.5	$	1.1	$	1.6
Asset impairments/Other(1)	1.6		1.8		3.4
Total	$	2.1	$	2.9	$	5.0
	Fiscal Year Ended December 31, 2023
	Cost of revenue		Selling, general  and administrative		Total
Severance and employee costs	$	0.1	$	1.1	$	1.2
Asset impairments/Other(1)	—		0.4		0.4
Total	$	0.1	$	1.5	$	1.6

(1) Includes facilities, inventory write-downs, plant and equipment write-downs, outside services, legal matters, and IT costs.

Schedule of Restructuring and Related Costs

The following table summarizes restructuring and impairment expenses for each reportable segment (in millions):

	Fiscal Year Ended December 31, 2025		Fiscal Year Ended December 31, 2024		Fiscal Year Ended December 31, 2023
Restructuring expenses and related asset impairments:
Medical	$	0.8	$	4.5	$	0.3
Nuclear & Safety	0.4		0.5		0.2
Corporate and other	—		—		1.1
Total	$	1.2	$	5.0	$	1.6

The following table summarizes the changes in the Company’s accrued restructuring balance for severance and employee costs, which are included in Accrued expenses and other current liabilities in the accompanying Consolidated Balance Sheets (in millions):

Balance at December 31, 2023	$	—
Restructuring charges (excluding impairments)	1.6
Payments	(1.4)
Adjustments	—
Balance at December 31, 2024	$	0.2
Restructuring charges	1.2
Payments	(1.1)
Adjustments	—
Balance at December 31, 2025	$	0.3